Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial

Documenti analoghi

• Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma
  di: Laura E. Chadsey, et al.
  Pubblicazione: (2025)
• Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs
  di: Lily Thorsen, et al.
  Pubblicazione: (2025)
• Brain Dose–Volume Thresholds and Survival in Dogs With Intracranial Tumours Treated With the 10 × 4 Gy Radiotherapy Schedule: A Combined Analysis of Two Trials
  di: Sergejs Unterkirhers, et al.
  Pubblicazione: (2025)
• Tolerability and Adverse Event Profile of Fixed Dose Rate Gemcitabine in Dogs With Neoplasia
  di: Evangelia J. Makrygiannis, et al.
  Pubblicazione: (2026)
• Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma
  di: Ilaria Maga, et al.
  Pubblicazione: (2025)